Role of patient experience in atypical antipsychotic adherence: A retrospective data analysis

Clinical Therapeutics

Volumn 29, Issue 12, 2007, Pages 2768-2773

  Vanelli, Mark ^a,b   Coca Perraillon, Marcelo ^b   Troxell Dorgan, Amy ^a  

^a Adheris Inc   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

antipsychotic adherence; risk for discontinuation

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; DATA ANALYSIS; EXPERIENCE; FEMALE; FOLLOW UP; HUMAN; HYPOTHESIS; KAPLAN MEIER METHOD; MALE; MEDICAL RECORD; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT SELECTION; PRESCRIPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION; TIME SERIES ANALYSIS; UNITED STATES;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; HUMANS; MALE; OUTPATIENTS; PATIENT COMPLIANCE; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 38049025690     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2007.12.023     Document Type: Article

References (15)

1. Lingam R., and Scott J. Treatment non-adherence in affective disorders. Acta Psychiatr Scand 105 (2002) 164-172
2. Mojtabai R., Lavelle J., Gibson P., et al. Gaps in use of antipsychotics after discharge by first-admission patients with schizophrenia, 1989 to 1996. Psychiatr Serv 53 (2002) 337-339
3. Vanelli M., Burstein P., and Cramer J. Refill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chain. Psychiatr Serv 52 (2001) 1248-1250
4. Valenstein M., Blow F., Copeland L., et al. Poor antipsychotic adherence among patients with schizophrenia: Medication and patient factors. Schizophr Bull 30 (2004) 255-264
5. Menzin J., Boulanger L., Friedman M., et al. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatr Serv 54 (2003) 719-723
6. Lieberman J., Stroup T., McEvoy J., et al., for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353 (2005) 1209-1223
7. Bechara A., Damasio H., Tranel D., and Damasio A. Deciding advantageously before knowing the advantageous strategy. Science 275 (1997) 1293-1295
8. Klein G. Sources of Power: How People Make Decisions (1998), MIT Press, Cambridge, Mass
9. Weiden P., Kozma C., Grogg A., and Locklear J. Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatr Serv 55 (2004) 886-891
10. Colom F., Vieta E., Martinez-Aran A., et al. Clinical factors associated with treatment noncompliance in euthymic bipolar patients. J Clinical Psychiatry 61 (2000) 549-555
11. Colom F., Vieta E., Tacchi M., et al. Identifying and improving nonadherence in bipolar disorders. Bipolar Disord 7 Suppl 5 (2005) 24-31
12. Ledoux J. The Emotional Brain: The Mysterious Underpinnings of Emotional Life (1996), Simon and Schuster, New York, NY
13. Osterberg L., and Blaschke T. Adherence to medication. N Engl J Med 353 (2005) 487-497
14. Woltmann E., Valenstein M., Welsh D., et al. Using pharmacy data on partial adherence to inform clinical care of patients with serious mental illness. Psychiatr Serv 58 (2007) 864-867
15. Mail-order prescriptions again show strongest growth. Drug Benefit Trends 15 (2003) 4